The Company’s deferred tax asset relates to net operating losses that may be carried forward to future years. At March 31, 2017, the Company has available net operating losses of $450,710 and $565,211 for federal and state income taxes, respectively, that expire from 2019 to 2037. For the years ended March 31, 2017 and 2016, $0 in federal net operating losses have expired, respectively. No tax benefit has been reported in the financial statements, because the Company believes there is a 50% or greater chance the carry-forwards will expire unused. Accordingly, the potential tax benefits of the loss carry-forward are offset by a valuation allowance of the same amount. The Company’s increase in valuation allowance of 20,231 and 18,059 during the years ended March 31, 2017 and 2016, respectively, were recorded to offset the deferred tax benefit of the Company’s tax losses for those years.

The Company’s deferred tax asset and valuation allowance as of March 31, 2017 and 2016 were as follows:

The Company’s provision for federal and state income taxes for the years ended March 31, 2017 and 2016 consisted of the following:

The Company’s effective tax rate differed from the federal statutory income tax rate for the years ended March 31, 2017 and 2016 as follows:

As of March 31, 2017 and 2016, the Company does not believe that it has taken any tax positions that would require the recording of any additional tax liability nor does it believe that there are any unrealized tax benefits that would either increase or decrease within the next twelve months. The Company’s income tax returns are subject to examination by the appropriate taxing jurisdictions. As of March 31, 2017, the Company’s income tax returns generally remain open for examination for three years from the date filed with each taxing jurisdiction.